Dual-pathway targeted therapy for decompensated cirrhosis: Combined transjugular intrahepatic portosystemic shunt and cyclooxygenase-2 inhibition
Journal of Translational Internal Medicine · 02.11.2026 · 14 (5) · 663-666
DOI: 10.1515/jtim-2026-0077 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Translational Internal Medicine, online erschienen am 24.08.2026. Verfasst von Yanting Ye und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
ORCID-Profile: Chengwei Tang
Zitieren
APA
Ye, Y., Huang, Z., Gao, J., & Tang, C. (2026). Dual-pathway targeted therapy for decompensated cirrhosis: Combined transjugular intrahepatic portosystemic shunt and cyclooxygenase-2 inhibition. Journal of Translational Internal Medicine, 14(5), 663-666. https://doi.org/10.1515/jtim-2026-0077
Vancouver
Ye Y, Huang Z, Gao J, Tang C. Dual-pathway targeted therapy for decompensated cirrhosis: Combined transjugular intrahepatic portosystemic shunt and cyclooxygenase-2 inhibition. Journal of Translational Internal Medicine. 2026;14(5):663-666. doi:10.1515/jtim-2026-0077
BibTeX
@article{Ye2026,
author = {Ye, Yanting and Huang, Zhiyin and Gao, Jinhang and Tang, Chengwei},
title = {Dual-pathway targeted therapy for decompensated cirrhosis: Combined transjugular intrahepatic portosystemic shunt and cyclooxygenase-2 inhibition},
journal = {Journal of Translational Internal Medicine},
year = {2026},
volume = {14},
number = {5},
pages = {663--666},
doi = {10.1515/jtim-2026-0077}
}
EUVIMED